Ensign Peak Advisors, Inc Spring Works Therapeutics, Inc. Transaction History

Ensign Peak Advisors, Inc

$51.2 Billion
Q1 2025

A detailed history of Ensign Peak Advisors, Inc transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 19,241 shares of SWTX stock, worth $900,478. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,241

Previous 19,041 1.05%

Holding current value

$900,478

Previous $687,000 23.58%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$32.5 - $59.93 $6,500 - $11,986	200 Added 1.05%	19,241 $849,000
Q4 2024 Feb 13, 2025	SELL	$28.61 - $42.55 $4.17 Million - $6.21 Million	-145,903 Reduced 88.46%	19,041 $687,000
Q3 2024 Nov 14, 2024	BUY	$32.04 - $42.76 $6,408 - $8,552	200 Added 0.12%	164,944 $5.28 Million
Q2 2024 Aug 13, 2024	BUY	$36.06 - $47.62 $2.27 Million - $3 Million	62,953 Added 61.85%	164,744 $6.21 Million
Q1 2024 May 14, 2024	BUY	$36.5 - $52.5 $2.99 Million - $4.29 Million	81,791 Added 408.96%	101,791 $5.01 Million
Q4 2023 Feb 14, 2024	BUY	$18.94 - $37.24 $378,800 - $744,800	20,000 New	20,000 $730,000
Q3 2022 Nov 14, 2022	SELL	$24.1 - $39.66 $1.7 Million - $2.8 Million	-70,499 Reduced 93.11%	5,220 $149,000
Q2 2022 Aug 12, 2022	SELL	$18.36 - $60.07 $706,327 - $2.31 Million	-38,471 Reduced 33.69%	75,719 $1.87 Million
Q1 2022 May 16, 2022	BUY	$48.97 - $65.46 $558,747 - $746,898	11,410 Added 11.1%	114,190 $6.45 Million
Q4 2021 Feb 11, 2022	BUY	$53.3 - $75.84 $1.1 Million - $1.56 Million	20,619 Added 25.1%	102,780 $6.37 Million
Q3 2021 Nov 12, 2021	BUY	$62.66 - $88.26 $1.1 Million - $1.55 Million	17,527 Added 27.12%	82,161 $5.21 Million
Q2 2021 Aug 13, 2021	BUY	$67.45 - $85.63 $1.38 Million - $1.75 Million	20,408 Added 46.14%	64,634 $5.33 Million
Q1 2021 May 12, 2021	BUY	$65.1 - $93.59 $1.18 Million - $1.7 Million	18,200 Added 69.93%	44,226 $3.25 Million
Q3 2020 Nov 12, 2020	BUY	$36.14 - $51.99 $600,755 - $864,229	16,623 Added 176.78%	26,026 $1.24 Million
Q1 2020 May 11, 2020	BUY	$20.44 - $41.21 $192,197 - $387,497	9,403 New	9,403 $254,000

Others Institutions Holding SWTX

# of Institutions

361

Shares Held

63.1M

Call Options Held

5.81M

Put Options Held

2.55M

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.92B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Spring Works Therapeutics, Inc. Transaction History